NL-OMON23481尚未招募不适用
Modulating regulatory T cell function in JIA with Vitamin B3 (nicotinamide) treatment
MC Utrecht, the Netherlands0 个研究点目标入组 30 人开始时间: 待定最近更新:
适应症
试验速览
- 阶段
- 不适用
- 状态
- 尚未招募
- 发起方
- 入组人数
- 30
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients with a diagnosis of oligo-articular or poly-articular JIA with active disease in 1 or multiple joints and an indication for intra-articular corticosteroid injection.
- •- Age between 4 to 18 years
排除标准
- •- no informed consent possible by patient/parents or caregivers
- •- participation in other interventional trials
研究者
相似试验
进行中（未招募）
1 期
A study to investigate the safety of additional treatment with Vitamin B3 in children with Juvenile Idiopathic Arthritis (JIA)Juvenile idiopathic arthritis (JIA)EUCTR2016-003643-10-NLMC Utrecht
撤回
2 期
Modulating regulatory T cell function in Juvenile Idiopathic Arthritis with Vitamin B3 (nicotinamide): a phase I/II trial focusing on safety and feasibility aspects in children with JIA.juvenile rheumatoid arthritisJuvenile idiopathic arthritisNL-OMON45620niversitair Medisch Centrum Utrecht45
撤回
不适用
Role of regulatory T cells in the pathogenesis of atopic dermatitis and psoriasis vulgaris.eczemapsoriasis10014982atopic dermatitisNL-OMON33107niversitair Medisch Centrum Utrecht84
已完成
2 期
ew regimen of therapy in the treatment of human BrucellosisBrucellosis.Brucellosis due to Brucella melitensisIRCT2014042617430N1Babol University of Medical Sciences60
已完成
不适用
Phenotype and number of regulatory T cells present in peripheral blood of COPD patients versus healthy controlsEmphysemachronic bronchitisNL-OMON30145niversitair Medisch Centrum Groningen50